Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) have earned a consensus rating of “Buy” from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have issued a report on […]

Related Keywords

United States , Thomasm Krummel , Piper Sandler , Alaleh Nouri , Nasdaq , Biorobotics Company Profile , Biorobotics Corporation , Blue Trust Inc , Biorobotics Co , Fairman Group , Securities Exchange Commission , Jump Financial , Get Free Report , Marketbeat Ratings , Truist Financial , Exchange Commission , Director Thomas , Jacobson Investment Advisors , Robotics Company , Get Free , Robotics Corporation , Aquabeam Robotic System , Robotics Daily ,